The non-discretionary and non-cyclical characteristics of healthcare sector have made it one of the most stable industries in recent times. As demographic shifts and societal changes are intensifying pressures on health systems and demanding new directions in the delivery of healthcare, a majority of the pharma and biopharma companies are spending up to 20% of their revenues in their R&D measures.

With its method-based engagements and client-centric consultative approach, Procurement Resource provides you with detailed buying and settlement process end-to-end, and delivers price and market forecast, success & risk factors analysis, supplier mapping, price analysis and benchmarking, spend analysis, cost reduction, and manufacturing equipment and machinery.

Sub Category